Terra Incognita
The blank spaces on the drug interaction map are not empty. Nobody went.
A woman arrives in the emergency department with chest pain. Her electrocardiogram is unrevealing, which is the ordinary case. So the question moves to a troponin, the blood test that finds injury to heart muscle. It comes back low.
Low is reassuring. Low sends people home.
She also takes a high-dose biotin supplement for her hair, and biotin breaks that test.
Most blood tests that hunt for one specific molecule are built around a chemical hook, and the hook is biotin. Flood the system with biotin from a supplement and the test stops reporting what is actually in the tube. Troponin comes back falsely low. The FDA warned about this in 2017, updated the warning in 2019 after the reports kept coming, and still keeps a list of troponin tests known to be vulnerable.
The vitamin did nothing to her heart. It corrupted the instrument we use to ask about her heart, and a falsely low troponin looks exactly like a low troponin.
We did not learn this from a study. We learned it from a body.
Nobody ran a trial of biotin in chest pain. There was no regulator who anticipated that a hair supplement would end up standing between a physician and a heart attack. The finding arrived the way these findings arrive. People took the supplement. Their results came back wrong in the direction that kills. Reports piled up until a signal rose out of the noise, and in the agency's own accounting of why it finally acted, that signal included a patient who died.
Old cartographers left unsurveyed territory blank and wrote terra incognita across it. Unknown land. They were honest about the limits of where they had actually walked.
Our maps are not.
What the list actually is
You have been handed a few of these warnings in your life. Grapefruit and cholesterol drugs. Blood thinners and salad. They arrive sounding like a complete list of what is dangerous.
They are a list of what somebody had a reason to check. A regulator required a study. A manufacturer needed an approval. Or people got hurt loudly enough to force a review.
Look at what gets checked.
There is one international rulebook for how drug interactions are studied. It was adopted in 2024, it is called ICH M12, and anyone can read it. It limits itself to interactions that work through the liver enzymes and cellular pumps that process medication. That is where one prescription collides with another, and it is a defensible place to spend the money.
Then it names what falls outside its borders. Interactions that work through absorption are out of scope, and the examples it gives are stomach acid, gut movement, and chelation.
Chelation is when a mineral clamps onto a drug in your gut and refuses to let go, so the drug never reaches your blood. It is how the calcium in your morning supplement disables your thyroid pill. It is how magnesium and zinc disable common antibiotics. The rulebook for studying drug interactions declares that entire mechanism to be someone else's problem.
Supplements appear in that document once. Researchers are told to exclude anyone using dietary supplements, herbal supplements, tobacco, alcohol, and certain foods and juices, so the data stay clean.
Read that again. In the design of the study, you are contamination. People who take supplements get removed from the room so the drug can be seen clearly.
Four places we did look
Thyroid medication. Calcium and iron clamp onto levothyroxine in the gut and cut how much of your dose actually gets absorbed, which is why the label says keep them four hours apart. It happens anyway, every morning, because swallowing all your pills at once is what a responsible person does. The thyroid tests stay abnormal, the dose gets raised, and the gland was working fine the entire time.
Metformin. The diabetes drug depletes vitamin B12 over years, and the label now says measure B12 every two to three years in everyone taking it. Low B12 causes numbness, burning, and unsteady walking. That is exactly the nerve damage everyone already blames on diabetes, so the symptom fits the disease and nobody thinks about the pill.
Notice how that instruction arrived. Metformin has been in wide use since the 1950s, and B12 sat in its labeling for decades as a suggestion, worth checking in people thought to be at risk. Only in recent years did the suggestion harden into a direction covering every patient. The interaction never changed. Our willingness to write it down did.
Orlistat. The weight-loss drug blocks fat absorption, which is the entire point, and vitamins A, D, E, and K travel through your body in fat. So the label tells you to take a multivitamin containing them and to separate it from the drug by two hours. Losing those vitamins is not a malfunction. It is the drug doing precisely its job to a molecule nobody was thinking about.
Warfarin. People on this blood thinner get told to avoid leafy greens, and that advice is wrong. The dose can be built around a steady amount of vitamin K in your diet. It cannot be built around an erratic one. The instruction is consistency, not avoidance.
The blank spaces
A drug and a supplement that appear together in no database have not been cleared. In the overwhelming majority of cases they have never been examined at all. Nothing is known about the pair.
Nothing known is a different condition from known to be safe. From where you stand, the two look identical.
So absence of evidence gets filed as evidence of absence, and the mistake stays invisible, because an interaction does not announce itself when it happens. It gets charged to something else. The disease is progressing. The treatment stopped working. You are getting older. You are anxious.
What to do
Know what is in the bottle, not just its category. "A multivitamin" is not information. Calcium, iron, zinc, magnesium, vitamin K, and five thousand micrograms of biotin is information. Bring the actual bottle to your appointment, or a photograph of the panel on the back.
Know the hour. Timing fixes more of this than quitting anything does. Four hours of separation rescues your thyroid pill. Two hours rescues the vitamins around orlistat. You do not have to give up the supplement, and moving it costs nothing.
Say it before your blood is drawn. If you take biotin, and it is in nearly every hair and nail product on the shelf, tell whoever is drawing the blood. If you are ever in an emergency department with chest pain, say it out loud even if nobody asks.
And when something new goes wrong, ask one question before accepting the obvious answer. Could this be the medication rather than the disease. That question is the one that costs people years, because the symptom usually fits the diagnosis they already have, and a thing that fits never gets examined.
Terra incognita
The list of known interactions will keep growing. It will grow the way it always has, one harm at a time, arriving years too late for the people it was about.
None of this is a reason to fear vitamins, and none of it says they are uniquely hazardous. It says they are biologically active, which is the entire reason you swallow them. A compound cannot be powerful enough to change how you feel and inert enough to ignore everywhere else.
The old mapmakers wrote terra incognita and meant it. Unknown. Unvisited. Not safe, not dangerous, simply unentered.
A blank space on the map has never meant the territory is empty.
Sources. Biotin interference with troponin: the FDA maintains a list of troponin assays subject to biotin interference; the underlying safety communications, issued in 2017 and updated in 2019, have since been archived off fda.gov. Scope of interaction studies: ICH M12, Drug Interaction Studies, adopted 2024, which superseded FDA's 2020 guidances. Levothyroxine, metformin, and warfarin prescribing information via DailyMed. Orlistat labeling via FDA Access Data.